Clinical Trial Update: Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intermittent hormonal therapy with leuprorelin and flutamide for advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprorelin (leuprorelin)
• flutamide (flutamide)

Snippet

Sponsor: Takeda | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED